Quick Takeaways
- GILEAD SCIENCES, INC. has 8 issuer positions tracked on this page.
- Estimated disclosed ownership value: $878,927,708.
- Recent insider filing activity is available below.
Insider Trading & Ownership of GILEAD SCIENCES, INC.
- Location
- Foster City, CA
- Summary
- The estimated value of insider holdings of GILEAD SCIENCES, INC. is at least $878,927,708 dollars as of 17 Feb 2026. GILEAD SCIENCES, INC. is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $371.44M. GILEAD SCIENCES, INC. is the 10%+ Owner of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $345.67M. GILEAD SCIENCES, INC. is the 10%+ Owner of ASSEMBLY BIOSCIENCES, INC. and owns shares of ASSEMBLY BIOSCIENCES, INC. (ASMB) stock worth about $100.29M. GILEAD SCIENCES, INC. is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $21.6M. GILEAD SCIENCES, INC. is the 10%+ Owner of LEAP THERAPEUTICS, INC. and owns shares of CYPHERPUNK TECHNOLOGIES INC. (CYPH) stock worth about $15.16M. GILEAD SCIENCES, INC. is the 10%+ Owner of HOOKIPA Pharma Inc. and owns shares of HOOKIPA Pharma Inc. (HOOK) stock worth about $13.6M. GILEAD SCIENCES, INC. is the 10%+ Owner of Allovir, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $11.16M.
- Signature
- Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow GILEAD SCIENCES, INC. and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Arcellx, Inc. ($371,444,668).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of GILEAD SCIENCES, INC.
ACLX
Forms 3/4/5
Arcellx, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $371,444,668
- Past year net change
- Change %
- Report period
- 28 Dec 2023
RCUS
Forms 3/4/5
Arcus Biosciences, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $345,672,360
- Past year net change
- Change %
- Report period
- 18 Feb 2025
ASMB
Forms 3/4/5
ASSEMBLY BIOSCIENCES, INC.
- Relationship
- 10%+ Owner
- Holdings value
- $100,290,003
- Past year net change
- Change %
- Report period
- 08 Aug 2025
XLO
Forms 3/4/5
Xilio Therapeutics, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $21,601,543
- Past year net change
- +$1,999,991
- Change %
- +10%
- Report period
- 13 Feb 2026
CYPH
Forms 3/4/5
LEAP THERAPEUTICS, INC.
- Relationship
- 10%+ Owner
- Holdings value
- $15,159,572
- Past year net change
- Change %
- Report period
- 10 Apr 2024
HOOK
Forms 3/4/5
HOOKIPA Pharma Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $13,600,612
- Past year net change
- Change %
- Report period
- 20 Dec 2023
KLRS
Forms 3/4/5
Allovir, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $11,158,950
- Past year net change
- Change %
- Report period
- 27 Jun 2023
KYTX
Forms 3/4/5
Kyverna Therapeutics, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- Past year net change
- Change %
- Report period
- 12 Feb 2024
Insider Transactions Reported by GILEAD SCIENCES, INC.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.